|
Real-time Estimate
Cboe BZX
17:07:42 29/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.145 USD | -1.15% |
|
-12.04% | -41.12% |
| 08-13 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 72.37M | - | - | - | ||
| 78.76B | - | ||||
| 75.12B | |||||
| 61.14B | |||||
| 46.07B | |||||
| 47.57B |
Select your edition
All financial news and data tailored to specific country editions
